Abstract: Nucleic acid constructs containing hybrid promoters for use in gene therapy and genetic manipulation. The invention relates to a nucleic acid construct for the precise, regulated expression of genes in host cells, which construct exhibits at least one mutation which inhibits the proper expression of the expressed gene and exhibits at least one additional second mutation which relieves the inhibition due to the first mutation, to an isolated cell which harbors the nucleic acid construct, and to the use of the nucleic acid construct for preparing pharmaceuticals and for treating diseases with excessive cell proliferation.
Abstract: Pharmaceutical compositions are described that comprise one or more active ingredients selected from the group consisting of anti-infective, anti-inflammatory and mucolytic agents, and particularly to compositions formulated as a solution in a unit dose for aerosol administration to treat chronic sinusitis.
Type:
Grant
Filed:
May 25, 2000
Date of Patent:
June 10, 2003
Assignee:
SinusPharma, Inc.
Inventors:
Robert S. Osbakken, Mary Anne Hale, Frederick T. Leivo, James D. Munk
Abstract: Compositions and methods using the compositions for treatment of peripheral hyperalgesia are provided. The compositions contain an anti-hyperalgesia effective amount of one or more compounds that directly or indirectly interact with peripheral opiate receptors, but that do not, upon topical or local administration, elicit central nervous system side effects.
Abstract: This invention relates to methods of analyzing a tissue sample from a subject. In particular, the invention combines morphological staining and/or immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) within the same section of a tissue sample. The analysis can be automated or manual. The invention also relates to kits for use in the above methods.
Type:
Grant
Filed:
October 7, 1998
Date of Patent:
June 3, 2003
Assignee:
Genentech, Inc.
Inventors:
Robert L. Cohen, Mary Beth Gardiner, Mark X. Sliwkowski, Gregory T. Stelzer
Abstract: Isolated cytohesin-PH peptides that can inhibit the beta-2 integrins from adhering, wherein the cytohesin-PH peptide has an amino acid sequence that comprises about a 140 amino acid domain from cytohesin-2. Assay kits comprising the peptides also are provided.
Abstract: A projection lens distortion error map is created using standard overlay targets and a special numerical algorithm. A reticle including a 2-dimensional array of standard overlay targets is exposed several times onto a photoresist coated silicon wafer using a photolithographic stepper. After exposure, the overlay targets are measured for placement error using a conventional overlay metrology tool. The resulting overlay error data is then supplied to a software program that generates a lens distortion error map for the photolithographic projection system.
Type:
Grant
Filed:
April 13, 2001
Date of Patent:
June 3, 2003
Assignee:
Litel Instruments
Inventors:
Adlai Smith, Bruce McArthur, Robert Hunter, Jr.
Abstract: Compositions and methods using the compositions for treatment of peripheral hyperalgesia are provided. The compositions contain an anti-hyperalgesia effective amount of one or more compounds that directly or indirectly interact with peripheral opiate receptors, but that do not, upon topical or local administration, elicit substantial central nervous system effects. The anti-diarrheal compound 4-(p-chlorophenyl)-4-hydroxy-N-N-dimethyl-&agr;,&agr;-diphenyl-1-piperidinebutyramide hydrochloride is preferred for use in the compositions and methods.
Type:
Grant
Filed:
August 16, 1999
Date of Patent:
June 3, 2003
Assignees:
Adolor Corporation, The Regents of the University of California
Abstract: Serial and parallel dispensing tools that can deliver defined and controlled volumes of fluid to generate multi-element arrays of sample material on a substrate surface are provided. The substrates surfaces can be flat or geometrically altered to include wells of receiving material. Also provided are tools that allow the parallel development of a sample array. To this end, the tool can be understood as an assembly of vesicle elements, or pins, where each of the pins can include a narrow interior chamber suitable for holding nanoliter volumes of fluid. Each of the pins can fit inside a housing that forms an interior chamber. The interior chamber can be connected to a pressure source that will control the pressure within the interior chamber to regulate the flow of fluid within the interior chamber of the pins. The prepared sample arrays can then be passed to a plate assembly that disposes the sample arrays for analysis by mass spectrometry.
Abstract: An apparatus for automatically gripping and retaining cargo on a platform includes spaced apart hooks for rotation from retracted positions beneath the platform to extended, cargo engaging positions, in which the hooks engage opposite sides or ends of the cargo; a pivot arm rotatably mounted in the platform and normally extending above the platform, the arm being moved downwardly by the cargo to operate linkage assemblies which cause the hooks to rotate upwardly to the cargo engaging positions. The hooks are returned to the retracted positions by foot pedal operated levers beneath the platform.
Abstract: A process for the isolation of clavulanic acid and pharmaceutically acceptable salts thereof, such as potassium clavulanate, from the aqueous fermentation broth of a clavulanic acid-producing microorganism comprises the microfiltration of the broth without prior treatment.
Abstract: The invention relates to substituted and unsubstituted 3H-benzo[1,2,3]oxathiazole 2,2-dioxides, 1,3-dihydrobenzo[1,2,5]thiadiazole 2,2-dioxides and 1,3-dihydro-benzo[c]isothiazole 2,2-dioxides, to their preparation and to their use in medicaments.
Type:
Grant
Filed:
August 9, 2001
Date of Patent:
May 20, 2003
Assignee:
Aventis Pharma Deutschland GmbH
Inventors:
Stefan Petry, Karl-Heinz Baringhaus, Swen Hoelder, Guenter Mueller
Abstract: The present invention relates to an immunodeficiency virus of drill monkeys, its RNA, the corresponding cDNA, proteins derived therefrom and fragments of the nucleic acids or proteins. The invention likewise relates to the diagnostic use of the nucleic acids and proteins mentioned and their fragments and to a diagnostic.
Type:
Grant
Filed:
July 26, 2000
Date of Patent:
May 20, 2003
Assignee:
Dade Behring Marburg GmbH
Inventors:
Lutz Gerhard Guertler, Hans Peter Hauser, Yvette Beatrice Dongmo Deloko, Leopold Zekeng, Lazare Kaptue
Abstract: This invention relates to methods for screening nucleic acids for polymorphisms by analyzing amplified target nucleic acids using mass spectrometric techniques and to procedures for improving mass resolution and mass accuracy of these methods of detecting polymorphisms.
Type:
Grant
Filed:
June 3, 1998
Date of Patent:
May 20, 2003
Assignee:
Sequenom, Inc.
Inventors:
Joseph A. Monforte, Thomas A. Shaler, Yuping Tan, Christopher H. Becker
Abstract: The invention relates to a system and methods for creating object-oriented objects, comprising data and method(s), without any source code being compiled; invoking the method(s) of the objects without compilation and generation of object code; and using such classes and objects to create a software application.
Type:
Grant
Filed:
April 7, 2000
Date of Patent:
May 20, 2003
Assignee:
EBEST!, Inc.
Inventors:
Andy Cheng, David Gary Deatherage, Jr., Xiaodi Zhang
Abstract: A novel polypeptide, designated neurotrophic factor-4 (NT-4), has been identified by PCR amplification of human genomic DNA. Provided herein is nucleic acid encoding NT-4 useful in diagnostics and in the recombinant preparation of NT-4. Also provided herein are nucleic acids encoding naturally occurring amino acid sequence variants of NT-4, designated NT-4&bgr;, NT-4&ggr;, and NT-4&Dgr;. The neurotropic factors of the invention are useful in the treatment of nerve cells and in diagnostic assays.
Abstract: A computer system updates a data object that is maintained in data storage external to a database management system (DBMS), after receiving an update request from a DBMS client for the data object, by first scheduling the update request with the DBMS to provide access to the external data object, then initiating a subtransaction in the DBMS for the update request, updating the data object with an in-place update action at the external data storage to thereby produce an updated data object and also updating the DBMS metadata of the data object, next appending information relating to type and time of the update action in an object version table, and then executing a backup operation of the updated data object. This permits update-in-place operations on the external data object, under supervision of the DBMS.
Type:
Grant
Filed:
December 16, 1999
Date of Patent:
May 13, 2003
Assignee:
International Business Machines Corporation
Abstract: The invention relates to the nucleic acid sequence and amino acid sequence of dihydrofolate reductase (DHFR) from mycobacteria and to expression of recombinant DHFR protein. Utilizing the recombinant protein, novel therapies and diagnostic strategies can be developed and selective antimycobacterial compositions can be designed and utilized to treat mycobacterial infections in patients. This invention includes all or portions of novel recombinant nucleic acids encoding DHFR for mycobacteria such as M. avium, to novel recombinant DHFR peptides produced by such sequences, and to vaccines, diagnostic kits, cells and therapies utilizing these peptides and nucleic acid sequences. The present invention relates to methods for using the sequences of the present invention to develop drugs specific to M. avium and other mycobacteria, to identify and sequence corresponding sequences in species other than M. avium, as well as diagnostic and treatment methods incorporating the disclosed sequences and peptides.
Type:
Grant
Filed:
August 12, 1999
Date of Patent:
May 6, 2003
Assignee:
Southern Research Institute
Inventors:
William W. Barrow, Sabrina Z. Van Ginkel, Thomas P. Dooley, William J. Suling
Abstract: A system and method operates with a document collection in which documents are represented as normalized document vectors. The document vector space is partitioned into a set of disjoint clusters and a concept vector is computed for each partition, the concept vector comprising the mean vector of all the documents in each partition. Documents are then reassigned to the cluster having their closest concept vector, and a new set of concept vectors for the new partitioning is computed. From an initial partitioning, the concept vectors are iteratively calculated to a stopping threshold value, leaving a concept vector subspace of the document vectors. The documents can then be projected onto the concept vector subspace to be represented as a linear combination of the concept vectors, thereby reducing the dimensionality of the document space.
Type:
Grant
Filed:
March 21, 2000
Date of Patent:
May 6, 2003
Assignee:
International Business Machines Corporation
Abstract: Mixtures containing a biological macromolecule, such as a nucleic acid molecule or a polypeptide, and a liquid matrix, which absorbs infrared (IR) radiation, are provided. These mixtures are useful for analysis of the biological macromolecule by IR matrix assisted laser desorption/ionization (IR-MALDI) mass spectrometry. Also provided are processes for analyzing a biological macromolecule using IR-MALDI mass spectrometry. For example, processes for detecting the presence or identity of a biological macromolecule in a sample, or for sequencing a biological macromolecule are provided.
Abstract: Methods are provided for developing medical diagnostic tests using decision-support systems, such as neural networks. Patient data or information, typically patient history or clinical data, are analyzed by the decision-support systems to identify important or relevant variables and decision-support systems are trained on the patient data. Patient data are augmented by biochemical test data, or results, where available, to refine performance. The resulting decision-support systems are employed to evaluate specific observation values and test results, to guide the development of biochemical or other diagnostic tests, too assess a course of treatment, to identify new diagnostic tests and disease markers, to identify useful therapies, and to provide the decision-support functionality for the test.